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Problem Identification
◦ Cancer is the leading cause of  death in Vermont and the second leading cause of  death in the U.S. 1 More 
than 1000 Vermonters die from cancer each year (Figure 1).2
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Figure 1. Age adjusted cancer mortality rates 
per 100,000 population, 2010-2014.2
◦ Cancer screening can lead to early detection, prolonging patients’ 
longevity and reducing deaths. Most primary care providers (PCP) 
use cancer screening guidelines developed by United States 
Preventive Services Task Force (USPST), but large disparities exist 
between the guidelines and the actual delivery and compliance of  
cancer screening.3 In a recent survey study which included 
Vermont providers, 76% of  PCP participants reported screening 
practices that were not in accordant with USPST recommendations 
for breast cancer.4
◦ A more effective risk-based screening system is needed to 
address this problem. 
Public Health Cost
◦ Cancer screening tests are expensive. The annual Medicare cost for breast cancer screening was $1.08 billion 
in the U.S.5 In order to reduce cost and resources, screening guidelines are progressing from age-based 
approach to more personalized risk-based approach. 
◦ Detecting cancer at earlier stage can reduce treatment costs. In a study of  8360 women diagnosed with breast 
cancer, the treatment costs were higher for those who were diagnosed at a more advanced stage (Figure 2).6
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Breast Cancer Stage at 
Diagnosis





Stage IV $182,655 
Figure 2. Breast cancer treatment costs based on stage at diagnosis.6
Community Perspective 
◦ “Primary care providers have limited time with each patient. During preventative visits, 
patients often bring up multiple acute issues that need to be addressed immediately. It is 
difficult for providers to conduct screening according to the constantly changing 
guidelines.” 
Family Medicine Physician at Milton, VT
◦ “I was so anxious about my risk for cancer due to my complex family history of  cancer. 
My wonderful primary doctor referred me to the genetic counseling specialists in order to 




◦ The Vermont Cancer Risk Questionnaire was developed by Dr. John King 
and Brian Sprague PhD. based on the risk factors of  common cancers. The 
questionnaire contains 20 questions which assessed risk factors for lung, 
colon, breast, prostate, and cervical cancer and reviewed cancer family 
history. The draft needed input from patients and clinicians. 
◦ Seven patients and three family medicine attendings/residents at the Milton 
clinic were interviewed. Participants were asked to fill out the questionnaire 
and to give specific feedback on the presentation, length, wording, and 
content of  the questionnaire. The chosen patient participants varied in age 
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• Simple for patients to understand




• #1: The columns for “If  
Current Smoker” and “If  
Former Smoker” are unclear
• #2 and #3: None of  the 
patients knew all the chemicals 
mentioned. 
• #20: The checkboxes make the 
table too complex to 
understand.
What needs to be 
changed?
• Ask about patient’s cancer history
• Instead of  screening exposure to the 
specific chemicals, screen for careers 
with high-risk to exposure 
• Use standardized race categories
• Utilize the cancer screening 
questions from BRFSS and compare 
the questionnaire results to national 
data 
Patient Demographics
Sex at birth Female Female Female Male Male Male Male
Age 21 25 56 28 47 51 59
Evaluation of  Effectiveness and Limitation
Effectiveness
◦ The questionnaire was mortified based on these feedbacks.
◦ After taking the survey, several patients expressed interests to learn about their cancer risk. A patient even 
expressed interest to learn about his family members’ cancer risk.
◦ Physicians were interested to learn about the implications of  this questionnaire for their practice.
Limitations
◦ The questionnaire is relevant to age 21-80, but the oldest interview participant is 59. 
◦ Since responses are self-reported, it is difficult to assess the accuracy of  patients’ responses. 
◦ Many patients asked for risk estimates after taking the questionnaire, but we are still in the process of  
developing an informational output system. 
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Future Steps
◦ Use cognitive interviewing techniques to assess the accuracy of  responses. Participants 
will think out loud as they complete the questionnaire. The interview will be repeated 
multiple times, and the responses of  each round will be compared. 
◦ Build the questionnaire into PRISM
◦ Implement the questionnaire at two UVMMC primary care clinics. The data will provide 
longitudinal data for developing a cancer risk prediction algorism. The goal of  this 
algorism is to guide cancer screening decision-making for clinicians and patients.
The author would like to thank the wonderful staff  at the Milton Family Practice for making this project possible.  
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